
DocGo (DCGO) Stock Forecast & Price Target
DocGo (DCGO) Analyst Ratings
Bulls say
DocGo is poised for strong growth in the coming years, with positive y/y volume growth across several core lines of business and successful expansion of its national payer relationship. Additionally, the company's focus on cost management and integration of its proprietary logistics platform and lower-cost staffing model contribute to strong margins and positioning in a large secular market for in-home clinical services. With a diverse portfolio and potential for mid-teens-plus earnings growth after 2026, DocGo has a promising outlook for continued success.
Bears say
DocGo is a healthcare company with two primary segments, Mobile Health Services and Transportation Services. Despite recent efforts to grow revenue and reduce costs, the company is facing challenges in ramping up business and achieving profitability. Additionally, their reliance on migrant-related revenue may have a negative impact on margins. Uncertainties around their ability to rightsize expenses and expand into new markets may further hinder their growth potential, leading to a discontinuation of coverage by analysts and a "show me" stance from investors.
This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.
DocGo (DCGO) Analyst Forecast & Price Prediction
Start investing in DocGo (DCGO)
Order type
Buy in
Order amount
Est. shares
0 shares